In addition, fibrosis-4 index (age, platelet, ALT, and AST) and NAFLD fibrosis score (age, hyperglycemia, BMI, platelet, albumin, and AST/ALT ratio) including AST and ALT levels are calculated to predict the NASH progression and severity in clinical settings. This evidence concerns the gene GPT and fibrosis.